Profile for Oxford Immunotec Global PLC (OXFD)
« Back to company indexOXFD Chatter Timeline
Stock Ticker for OXFD
Most Active Tweeters for OXFD
| User | Tweets |
|---|---|
| @ConsumerFeed | 6 |
| @WeekHerald | 5 |
| @TickerReport | 5 |
| @WatchlistN | 5 |
| @TheMarketsDaily | 4 |
Recent Tweets for OXFD
 |
@TickerReport Critical Review: Oxford Immunotec Global $OXFD and Intellia Therapeutics $NTLA https://t.co/qY6VEgquzu May 25th 2018, 5:05pm |
 |
@WatchlistN Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD Will Announce Quarterly Sales of $28.55 Million https://t.co/Q0z1LYKXoe May 25th 2018, 4:05pm |
|
@TickerReport Oxford Immunotec Global $OXFD Rating Increased to Buy at BidaskClub https://t.co/IsFNt85gzb May 25th 2018, 12:05pm |
 |
@ConsumerFeed Oxford Immunotec Global $OXFD Raised to “Hold” at Zacks Investment Research https://t.co/rkEA0LCpup May 25th 2018, 12:05pm |
 |
@ledgerzette $28.55 Million in Sales Expected for Oxford Immunotec Global PLC $OXFD This Quarter https://t.co/2EpNgOilB6 May 25th 2018, 11:05am |
 |
@registrarjourn Oxford Immunotec Global $OXFD Raised to “Hold” at Zacks Investment Research https://t.co/wCZABhcHUA May 25th 2018, 7:05am |
 |
@WeekHerald Critical Analysis: Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD https://t.co/gTVJ2jxZc9 May 24th 2018, 5:05pm |
 |
@TranscriptDaily Critical Analysis: Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD https://t.co/pi1mmzxG7V May 24th 2018, 5:05pm |
 |
@TheMarketsDaily Oxford Immunotec Global $OXFD Rating Increased to Hold at Zacks Investment Research https://t.co/QHthlxbSvk May 24th 2018, 7:05am |
|
@WeekHerald Oxford Immunotec Global $OXFD Rating Increased to Hold at Zacks Investment Research https://t.co/bssSCtdktQ May 24th 2018, 6:05am |
 |
@dailypoliticaln Oxford Immunotec Global $OXFD Stock Rating Upgraded by BidaskClub https://t.co/34tGEx3LfY May 24th 2018, 5:05am |
|
@ConsumerFeed Research Analysts’ Recent Ratings Updates for Oxford Immunotec Global $OXFD https://t.co/InLVQM9Ds0 May 23rd 2018, 2:05pm |
|
@ledgerzette Oxford Immunotec Global $OXFD Upgraded to “Buy” at BidaskClub https://t.co/SFhylMZtVl May 23rd 2018, 6:05am |
|
@TickerReport -$0.24 Earnings Per Share Expected for Oxford Immunotec Global PLC $OXFD This Quarter https://t.co/FPHJDtgPw7 May 23rd 2018, 5:05am |
|
@ConsumerFeed Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD to Announce -$0.24 EPS https://t.co/eLGXOgkskk May 23rd 2018, 5:05am |
|
@ConsumerFeed Oxford Immunotec Global $OXFD Upgraded to “Buy” at BidaskClub https://t.co/Uo2XBJ6CBW May 23rd 2018, 5:05am |
|
@WatchlistN Oxford Immunotec Global $OXFD Upgraded to Hold at Zacks Investment Research https://t.co/mbMNGNKKzs May 23rd 2018, 4:05am |
|
@WatchlistN Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD Head-To-Head Analysis https://t.co/ve6KB81SE9 May 23rd 2018, 4:05am |
|
@TickerReport Oxford Immunotec Global $OXFD Upgraded to Hold at Zacks Investment Research https://t.co/VNb4h7tWb7 May 23rd 2018, 4:05am |
 |
@odibro $OXFD Announces Launch of the Accutix™ Brand for its tick- borne disease offering https://t.co/rWfmlMfwaM May 22nd 2018, 8:05am |
 |
@stockelite $OXFD Oxford Immunotec Announces Launch of the Accutix™ Brand https://t.co/XNaCw8yZHQ May 22nd 2018, 8:05am |
 |
@GNWLive Oxford Immunotec Announces Launch of the Accutix™ Brand $OXFD https://t.co/faItbTFbR5 May 22nd 2018, 8:05am |
 |
@dakotafinancial Oxford Immunotec Global $OXFD Raised to Buy at BidaskClub https://t.co/hlTFXdRcLn May 22nd 2018, 7:05am |
|
@TheMarketsDaily Oxford Immunotec Global $OXFD Raised to Buy at BidaskClub https://t.co/RM0b8wlCa6 May 22nd 2018, 7:05am |
 |
@ZolmaxNews Zacks Investment Research Upgrades Oxford Immunotec Global $OXFD to Hold https://t.co/qScFPuEfpV May 22nd 2018, 6:05am |
|
@dailypoliticaln Zacks Investment Research Upgrades Oxford Immunotec Global $OXFD to Hold https://t.co/v8uFJfHusk May 22nd 2018, 6:05am |
 |
@AmericanBanking Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD Will Post Quarterly Sales of $28.55 Million https://t.co/GUZOzyYhZE #stocks May 22nd 2018, 2:05am |
|
@TickerReport Zacks: Analysts Expect Oxford Immunotec Global PLC $OXFD Will Post Quarterly Sales of $28.55 Million https://t.co/aHUczxTAvb May 22nd 2018, 2:05am |
|
@dailypoliticaln Oxford Immunotec Global PLC $OXFD Expected to Announce Quarterly Sales of $28.55 Million https://t.co/VNAABMx1kG May 22nd 2018, 2:05am |
|
@stockelite $OXFD Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential Diagnosti… https://t.co/gg2eYpXe4d May 21st 2018, 4:05pm |
 |
@portefeuillefun RT @GNWLive: Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential $OXFD https://t.co/i9R5O6Q… May 21st 2018, 4:05pm |
|
@GNWLive Oxford Immunotec’s T-SPOT®.TB Test Included in the World Health Organization’s First-Ever Essential $OXFD https://t.co/i9R5O6QBBU May 21st 2018, 4:05pm |
|
@AmericanBanking Brokerages Anticipate Oxford Immunotec Global PLC $OXFD to Announce -$0.24 Earnings Per Share https://t.co/tT7zc1ZH6B #stocks May 20th 2018, 7:05pm |
|
@WatchlistN Zacks: Analysts Anticipate Oxford Immunotec Global PLC $OXFD Will Announce Earnings of -$0.24 Per Share https://t.co/7rwVQ04TDG May 20th 2018, 7:05pm |
 |
@ThisLincolnian Brokerages Anticipate Oxford Immunotec Global PLC $OXFD to Announce -$0.24 Earnings Per Share https://t.co/px39Cmz6YD May 20th 2018, 7:05pm |
|
@WeekHerald Financial Contrast: Intellia Therapeutics $NTLA versus Oxford Immunotec Global $OXFD https://t.co/lgE09wDWdF May 20th 2018, 6:05am |
|
@AmericanBanking Financial Contrast: Intellia Therapeutics $NTLA versus Oxford Immunotec Global $OXFD https://t.co/3RQDviy5wB #stocks May 20th 2018, 1:05am |
|
@ConsumerFeed Intellia Therapeutics $NTLA and Oxford Immunotec Global $OXFD Head to Head Analysis https://t.co/Q4lfGcL96P May 20th 2018, 1:05am |
|
@GNWLive Oxford Immunotec to Present at the 2018 UBS Global Healthcare Conference $OXFD https://t.co/qopvPEFgIw May 16th 2018, 9:05am |
|
@ConsumerFeed Oxford Immunotec Global $OXFD Downgraded to “Hold” at BidaskClub https://t.co/pMG4pjvfk6 May 15th 2018, 4:05am |
|
@ZolmaxNews Oxford Immunotec Global $OXFD Downgraded to “Hold” at BidaskClub https://t.co/MKDHMgZrPu May 15th 2018, 4:05am |
 |
@dispatchtribune BidaskClub Downgrades Oxford Immunotec Global $OXFD to Hold https://t.co/4anqy7Q0M0 May 14th 2018, 11:05am |
 |
@OlympiaReport Oxford Immunotec Global $OXFD Stock Rating Lowered by BidaskClub https://t.co/aExzDNqgg8 May 13th 2018, 2:05pm |
|
@TheMarketsDaily Oxford Immunotec Global $OXFD Earning Somewhat Positive Press Coverage, Report Shows https://t.co/AkJpc1k4Q0 May 13th 2018, 2:05pm |
|
@dakotafinancial Somewhat Positive News Coverage Somewhat Unlikely to Affect Oxford Immunotec Global $OXFD Share Price https://t.co/ZngSXa8HBC May 13th 2018, 2:05pm |
 |
@EnterpriseLeade $28.55 Million in Sales Expected for Oxford Immunotec Global $OXFD This Quarter https://t.co/kCmCEoHzs8 May 12th 2018, 9:05pm |
|
@ThisLincolnian Zacks: Analysts Anticipate Oxford Immunotec Global $OXFD Will Announce Quarterly Sales of $28.55 Million https://t.co/pxCIBR0eaX May 12th 2018, 9:05pm |
|
@dakotafinancial Oxford Immunotec Global $OXFD Given Average Recommendation of “Hold” by Analysts https://t.co/BDG9obX8tL May 12th 2018, 8:05pm |
|
@WeekHerald Oxford Immunotec Global $OXFD Given Average Recommendation of “Hold” by Analysts https://t.co/wdyTcfiY2D May 12th 2018, 8:05pm |
|
@TheMarketsDaily Oxford Immunotec Global $OXFD Receives $18.25 Average PT from Brokerages https://t.co/2zogazG75x May 12th 2018, 8:05pm |
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.